# DIBBS #SPE2DS-27-T-1402

DLA procurement of monoclonal anti-A blood grouping serum

**Posted:** November 04, 2026
**Respond By:** November 09, 2026
**Identifier:** SPE2DS-27-T-1402
**NAICS:** 325414, 424210

DLA is seeking two packages of monoclonal anti-A blood grouping serum for medical use.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain; buyer contact listed as Seth Tootell.
- **OEMs / approved sources:** **Ortho Diagnostic Systems Inc.** (P/N 711220) and **CD Acquisition Holdings Inc.** (P/N B5209A). The solicitation identifies both as approved sources.
- **Product:** Two packages of 15, 10 mL each, of monoclonal anti-A blood grouping serum; NSN 6550-01-317-0288. Used to identify antigen A on red blood cells for ABO blood-group determination.
- **Requirements:** FDA-regulated product; maintain refrigeration at 2–8°C. The serum has a 15-month, non-extendable shelf life, with at least 13 months remaining at delivery.
- **Delivery:** FOB destination to the U.S. Army Medical Materiel Center Europe, required 84 days after award.

### Description

BLOOD GROUPING SERUM, A (QTY: 2, NSN: 6550-01-317-0288, Purchase Request: 7018991828)
  Approved Sources:
  - CAGE: 61829, Part No: 711220
  - CAGE: 64767, Part No: B5209A
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DS27T1402)